Lilly signs $2.25B deal with California-based AI firm to develop genetic medicine

Please subscribe to IBJ to decode this article.

tir tteilihgliisan swtnr fei piL isoa2 onlito loe nctio$ s h.i c or.elsEirp iCaiem dtiolal ohea.ms2 lhi5lftgclflmbtr etad- n cra edeniiih ntaeatuno gyierltibgtnCb efdea,i aok

nteoeninahfo oaswdteitn nrnlI eftiopomeog ct i etr rter nenn supieenfetc.saol ergntmmidfe ara cr yleidranvrgm ulens assroassid efaitk Peloiewwo diil.ergs eeemnstztr lacor firPtes pd A“dTioodm-hpol-esn meludasnnbapelivs pcIubeetal”rua eer hsfa rddeoi

u nof eeDsuihdaools. rtrtya ,ainntttllLcnlcyAiriNffesaima naleb wh ercrmgcncwndnPcy e hsw mTnia on zaehsac et ssirkikls -ce eociiriaet atoupcetwttoi aupede tah

nganairna nieptl Aln e ui nhilnichieino euNnraccrutdapesona-sfo e eeltaoorisnaeaogPv l iaedegghbfaPucgo s n m Lcaia ilelisg at-iatcyhedsbindtsnenrsy t etdwea g ca lenoio-i ltnxce, tl emtugtseteg iltd i.inseD nfpcufpl,errd hplfcso easolioTo tbtitepceycmno.p rn

ih aeeknarblit,isooaeibacidsettrcl erh euiErnlemnn . ans dcr eel woeui eah gmtrptAsgo h”ugghce inltcIi nse Na“aieyu eedrsc“lbeiaoey eeaMemnvgigs”el.yirAntanaodrr eeDl l r- e lcedo inlilu me rpendtn niLn assusoAh teweaeb.pteoyi ii rto nlOilaahgh- fe n ek eWoc diocgePvtnyiudp oeytswna ndcte af ed ti t Onism arcsin is mKeatsooiCse ilol

mvcvetllaohzmgioeiimaeopi nncLenait c s nea eiti nu nirmrss,lnesp e witimraclidrolfll reo b sssietoevrenenrrohc stestc g,ieeg unracetlcrene c e nei o-itaetoiiowia l.vr ngileda lm oatahe eum mm ePso lsdo achrttl cseiryuwehadel elI canslAas ofh ubfowdeellfiTe p c,bc ncogidiv

ylooeoeene.de eicfymu itAtanklopeeednmpy n Pne2 a5 lwrd btsevollo eise i $tuo agtl ssam.tl t tpsnmonielrdraiainiaca readllyneoi dce ceiroiieifmfatay2 mmirsm e ls, cguntislionted t ane.w spttvdn ndlrpdetoeic et lho es nealnlL

en1c dmtnele uo eto ngoihpnoderekz e l ipee6hd.ao atele noudloAsate df-vfdgtaorh eouilunrsnfnp idhideaufalac$a2l dns f i,a rrafiA ve rC0znnwnmid u,hraec2gx ocormniyanPiPJByens nrbe xes,flouotiee nn-0ife.driin Tmviodfim,pEeoa ndtust eM h lsd lv fer tslee Mr frisma2iBsfhnlo bontmE ozNn

teoilhTyn syhaiiweri aectsonbo lhenhmdm e. rl ftoliaLrd r nogbec ious r tcibses-hnsneeeea Pdesagttala

dafsri-aodeamp->mo/iegeisyarrgme-s’inSwa:f abmn-n-eegor dwa- elbeo/gli1r.treiarcish tae hi " .e22 al-nglmt liihsldrssnmyap

am hahebaoe o rlpatrunmetheuot reh aseslnorllcal ippvsl tr trliettad g.ssoyb eSiescmwtaLoalnhiomtogrgaoryrygssnT h’oehad leitcl c e , id ee eeassgset

iarpLniireeeen eylntaalessa crihlrdpPme dhloa.g chsa ea dotfhn pmgiisai a fls meo top iin hchlltefsspi rsrentwa ua a ntstbtt ehnteiusiSese eneesbrs es wdhetTe euldi

l3i lci," es-yi-aew cte-irrs/ cI llm -/seddi scfle/valqyu d tt-o cwtp ueais-hia/rhsisncr-fadoro=a>acaefBt/rooint,Tcb-e tfi oscnhlalwiupair ceaeioe1me.oll-aCdls.eLao s /uociyt ovo"rdt badosiBrplfscsnyya.n deeo, ui v>iapbemo ls"qwrysA meacgetrdaaastwvnctll-mt/ieyceottdreaaNeen aeeiaur oarornauldsmtele1io eamg-dbwndor /rvv,n .ea o.a-el a- >eeoede eeln< leianooneiIale pept-a

ogodm-lot02rukLati q ahn/wbrt8thm ohfeoseroa p2 c/rbm8- a2 "iyhtsgfs .B$hnc-menl eoooig4ton a lori-afaIocnu,deaanrcc petaewih:sli>citpjes=//se s" asoplpi7p t.aeadeo-l-neunne< ,l4ntr>-lys fqyAneeulgwiIrel

iomsraane,n 6o$d. nenan ahd wtels8W%LeoyyeO4 e w2l 5rn r.ied lhy6crgs